| Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation R Childs, A Chernoff, N Contentin, E Bahceci, D Schrump, S Leitman, ... New England Journal of Medicine 343 (11), 750-758, 2000 | 1331 | 2000 |
| Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses R Childs, E Clave, N Contentin, D Jayasekera, N Hensel, S Leitman, ... Blood, The Journal of the American Society of Hematology 94 (9), 3234-3241, 1999 | 676 | 1999 |
| Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units JJ Molldrem, E Clave, YZ Jiang, D Mavroudis, A Raptis, N Hensel, ... Blood, The Journal of the American Society of Hematology 90 (7), 2529-2534, 1997 | 302 | 1997 |
| A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation K Talvensaari, E Clave, C Douay, C Rabian, L Garderet, M Busson, ... Blood, The Journal of the American Society of Hematology 99 (4), 1458-1464, 2002 | 274 | 2002 |
| Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect RW Childs, E Clave, J Tisdale, M Plante, N Hensel, J Barrett Journal of clinical oncology 17 (7), 2044-2044, 1999 | 239 | 1999 |
| Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation E Clave, M Busson, C Douay, R Peffault de Latour, J Berrou, C Rabian, ... Blood, The Journal of the American Society of Hematology 113 (25), 6477-6484, 2009 | 182 | 2009 |
| T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect AJ Barrett, D Mavroudis, J Tisdale, J Molldrem, E Clave, C Dunbar, ... Bone marrow transplantation 21 (6), 543-551, 1998 | 178 | 1998 |
| Th17/Treg ratio in human graft-versus-host disease P Ratajczak, A Janin, R Peffault de Latour, C Leboeuf, A Desveaux, ... Blood, The Journal of the American Society of Hematology 116 (7), 1165-1171, 2010 | 158 | 2010 |
| Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never again A Toubert, S Glauzy, C Douay, E Clave Tissue antigens 79 (2), 83-89, 2012 | 147 | 2012 |
| Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis D Farge, C Henegar, M Carmagnat, M Daneshpouy, Z Marjanovic, ... Arthritis & Rheumatism 52 (5), 1555-1563, 2005 | 145 | 2005 |
| Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy E Clave, F Agbalika, V Bajzik, RP de Latour, M Trillard, C Rabian, ... Transplantation 77 (1), 76-84, 2004 | 115 | 2004 |
| Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation E Clave, V Rocha, K Talvensaari, M Busson, C Douay, ML Appert, ... Blood 105 (6), 2608-2613, 2005 | 100 | 2005 |
| Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients LCM Arruda, KCR Malmegrim, JR Lima-Júnior, E Clave, JBE Dias, ... Blood Advances 2 (2), 126-141, 2018 | 94 | 2018 |
| Expansion of highly differentiated cytotoxic terminally differentiated effector memory CD8+ T cells in a subset of clinically stable kidney transplant recipients: a potential … M Yap, F Boeffard, E Clave, A Pallier, R Danger, M Giral, J Dantal, ... Journal of the American Society of Nephrology 25 (8), 1856-1868, 2014 | 91 | 2014 |
| Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation S Servais, E Lengline, R Porcher, M Carmagnat, RP de Latour, M Robin, ... Biology of Blood and Marrow Transplantation 20 (4), 507-517, 2014 | 85 | 2014 |
| Identification of multiple HLA-A* 0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients SG Fonseca, H Moins-Teisserenc, E Clave, B Ianni, VL Nunes, C Mady, ... Microbes and infection 7 (4), 688-697, 2005 | 84 | 2005 |
| Outcomes, infections, and immune reconstitution after double cord blood transplantation in patients with high‐risk hematological diseases A Ruggeri, R Peffault de Latour, M Carmagnat, E Clave, C Douay, ... Transplant Infectious Disease 13 (5), 456-465, 2011 | 73 | 2011 |
| Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation H Moins-Teisserenc, M Busson, C Scieux, V Bajzik, JM Cayuela, E Clave, ... The Journal of infectious diseases 198 (6), 818-826, 2008 | 72 | 2008 |
| Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients D Farge, LCM Arruda, F Brigant, E Clave, C Douay, Z Marjanovic, ... Journal of Hematology & Oncology 10, 1-9, 2017 | 70 | 2017 |
| CD158k is a reliable marker for diagnosis of Sézary syndrome and reveals an unprecedented heterogeneity of circulating malignant cells H Moins-Teisserenc, M Daubord, E Clave, C Douay, J Félix, ... Journal of Investigative Dermatology 135 (1), 247-257, 2015 | 70 | 2015 |
Antoine ToubertINSERM U1160, Université Paris Diderot, Sorbonne Paris CitéVerified email at univ-paris-diderot.fr
